[HTML][HTML] Baseline PET/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review

R Frood, C Burton, C Tsoumpas, AF Frangi… - European journal of …, 2021 - Springer
Purpose To systematically review the literature evaluating clinical utility of imaging metrics
derived from baseline fluorine-18 fluorodeoxyglucose positron emission …

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

L Vercellino, R Di Blasi, S Kanoun, B Tessoulin… - Blood …, 2020 - ashpublications.org
Chimeric antigen receptor (CAR) T-cell therapy has emerged as an option for
relapsed/refractory aggressive B-cell lymphomas that have failed 2 lines of therapy. Failures …

The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma

SF Barrington, J Trotman - The Lancet Haematology, 2021 - thelancet.com
This Review focuses on the use of 18 F-fluorodeoxyglucose (18 F-FDG) PET in the
assessment of diffuse large B-cell lymphoma, follicular lymphoma, and peripheral T-cell …

[HTML][HTML] Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: international metabolic prognostic index

NG Mikhaeel, MW Heymans, JJ Eertink… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
PURPOSE Baseline metabolic tumor volume (MTV) is a promising biomarker in diffuse large
B-cell lymphoma (DLBCL). Our aims were to determine the best statistical relationship …

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

L Vercellino, AS Cottereau… - Blood, The Journal …, 2020 - ashpublications.org
Early identification of ultra-risk diffuse large B-cell lymphoma (DLBCL) patients is needed to
aid stratification to innovative treatment. Previous studies suggested high baseline total …

Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural …

P Blanc-Durand, S Jégou, S Kanoun… - European Journal of …, 2021 - Springer
Purpose Lymphoma lesion detection and segmentation on whole-body FDG-PET/CT are a
challenging task because of the diversity of involved nodes, organs or physiological …

Deep-learning 18F-FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma

N Capobianco, M Meignan, AS Cottereau… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Total metabolic tumor volume (TMTV), calculated from 18F-FDG PET/CT baseline studies, is
a prognostic factor in diffuse large B-cell lymphoma (DLBCL) whose measurement requires …

Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP

CL Freeman, KJ Savage, DR Villa… - Blood, The Journal …, 2021 - ashpublications.org
Consolidative radiation therapy (RT) for advanced-stage diffuse large B-cell lymphoma
(DLBCL) remains controversial, with routine practice continuing to include RT in patients …

[HTML][HTML] Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT

AS Cottereau, M Meignan, C Nioche, N Capobianco… - Annals of …, 2021 - Elsevier
Background We analyzed the prognostic value of a new baseline positron emission
tomography (PET) parameter reflecting the spread of the disease, the largest distance …

Automated segmentation of baseline metabolic total tumor burden in diffuse large B-cell lymphoma: which method is most successful? A study on behalf of the PETRA …

SF Barrington, BGJC Zwezerijnen… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Metabolic tumor volume (MTV) is a promising biomarker of pretreatment risk in diffuse large
B-cell lymphoma (DLBCL). Different segmentation methods can be used that predict …